Cantourage is introducing the second Clever Leaves medical cannabis product – IQANNA – in Germany.
IQANNA No 10 is a high-THC dried flower product based on the Wappa cultivar, and is currently produced at Clever Leaves’ Portugal facility. The product will now be available for patients in German pharmacies.
The expanded partnership is a bid to increase the range of high-quality medical cannabis products that Cantourage has been making available to the EU market.
CEO of Clever Leaves, Andres Fajardo, stated: “Broadening distribution is an important goal, and we are delighted that the successful strategic partnership with Cantourage has allowed us to take this next step in bringing our high-quality products and brands into the European market.
Read more: Germany’s legalisation push has lit up the European cannabis market
“We are excited about the opportunity to play a role in meeting the needs of the quickly growing key markets of Germany and Europe.”
Cantourage processes the Wappa-based IQANNA No 10 cannabis flowers, transforming them to medical cannabis products with one of the highest THC levels available in German pharmacies. IQANNA No 10 is the second Clever Leaves product made available to patients in Germany, with further products under the IQANNA brand to be introduced in the country in the coming weeks.
CEO of Cantourage, Philip Schetter, commented: “Today’s launch of the IQANNA No 10 medical cannabis flowers is an important step in our intensified partnership with Clever Leaves and further improves the already growing range of medical cannabis products available to German pharmacies and patients.
“Clever Leaves is a large-scale and experienced multinational operator with sustainable operations and excellent quality products from countries with exceptional natural growing conditions. We very much look forward to further deepening our partnership and making further Clever Leaves products available to German patients, among whom we know that demand levels are very high.”
Managing director of Clever Leaves Germany, Caroline Kliess, commented: “We are excited to intensify our partnership with Cantourage and launch our next medical cannabis flower product under the IQANNA brand.”
[activecampaign form=31]
